The store will not work correctly when cookies are disabled.
methyl (2R,5S)-2-methoxy-7-methyl-2-oxo-5-pentyl-4,5-dihydro-3H-1,2lambda5-oxaphosphepine-6-carboxylate
ID: ALA5205745
PubChem CID: 168294250
Max Phase: Preclinical
Molecular Formula: C14H25O5P
Molecular Weight: 304.32
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCC[C@H]1CC[P@@](=O)(OC)OC(C)=C1C(=O)OC
Standard InChI: InChI=1S/C14H25O5P/c1-5-6-7-8-12-9-10-20(16,18-4)19-11(2)13(12)14(15)17-3/h12H,5-10H2,1-4H3/t12-,20+/m0/s1
Standard InChI Key: PDEQHOMCAFKFDK-FKIZINRSSA-N
Molfile:
RDKit 2D
20 20 0 0 0 0 0 0 0 0999 V2000
-3.0559 1.6649 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
-2.4077 2.1753 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.6032 1.9915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2444 1.2508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6027 0.5009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4077 0.3170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0559 0.8322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0189 2.5757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4697 2.3816 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.8820 1.6649 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.2949 0.9496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4184 1.2508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0055 1.9663 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0055 0.5355 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.8204 0.5355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0186 -0.0829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2324 -0.8807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6484 -1.4648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1492 -1.2508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7332 -1.8350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
1 7 1 0
7 6 1 0
3 8 1 0
1 9 2 0
1 10 1 1
10 11 1 0
4 12 1 0
12 13 2 0
12 14 1 0
14 15 1 0
5 16 1 1
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 304.32 | Molecular Weight (Monoisotopic): 304.1440 | AlogP: 3.89 | #Rotatable Bonds: 6 |
Polar Surface Area: 61.83 | Molecular Species: ┄ | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.59 | CX LogD: 2.59 |
Aromatic Rings: ┄ | Heavy Atoms: 20 | QED Weighted: 0.42 | Np Likeness Score: 0.35 |
References
1. Cavalier JF, Spilling CD, Durand T, Camoin L, Canaan S.. (2021) Lipolytic enzymes inhibitors: A new way for antibacterial drugs discovery., 209 [PMID:33071055] [10.1016/j.ejmech.2020.112908] |